3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
2
Stomach Neoplasms
1
Peritoneal Neoplasms
1
Lung Neoplasms
1
Endocrine Gland Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
5
Cisplatin
4
Paclitaxel
3
lenvatinib
2
Fluorouracil
2
trastuzumab deruxtecan
1
sargramostim
1
resiquimod
1
poly ICLC
1
oregovomab
1
liposomal doxorubicin
1
fluoroazomycin arabinoside
1
fludarabine
1
cemiplimab
1
catumaxomab
1
cabozantinib
1
Therapeutics
1
Therapeutic Irrigation
1
TKM-080301
1
Radiation, Ionizing
1
Radiation
1
Quality of Life
1
Proctoscopy
1
Prednisone
1
Prednisolone
1
Patient Reported Outcome Measures
1
Papanicolaou Test
1
Oxaliplatin
1
Nelfinavir
1
Molecular Diagnostic Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Therapeutic Irrigation
×
Gynecologic
×
Clear all
NCT01476553
2017-05-02
EIPL
Universitätsmedizin Mannheim
Phase NA
Terminated
30 enrolled